Articles with the topic: featured

Gene silencing for HD: the story so far

Gene silencing for HD: the story so far

Is gene silencing as exciting as it sounds for HD, and what might the future hold?

Professor Ed WildMarch 22, 2011

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis

HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc

Professor Ed WildMarch 14, 2011

Interview: CHDI Management

Interview: CHDI Management

HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide

Dr Jeff CarrollFebruary 25, 2011

CHDI Report: Day 3

CHDI Report: Day 3

Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies

Dr Jeff CarrollFebruary 10, 2011

CHDI Report: Day 2

CHDI Report: Day 2

Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD

Professor Ed WildFebruary 09, 2011

CHDI Report: Day 1

CHDI Report: Day 1

Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene

Dr Jeff CarrollFebruary 08, 2011

Welcome to HDBuzz

Welcome to HDBuzz

Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co

Professor Ed WildJanuary 18, 2011

Is Huntington’s disease twice as common as we thought?

Is Huntington’s disease twice as common as we thought?

New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk

Professor Ed WildNovember 27, 2010

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Merger of two major Huntington’s Disease observational trials creates ENROLL-HD

Dr Jeff CarrollNovember 24, 2010